AMBER LOWERY: Open Payments
NPI 1154832681 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,189 in 135 payments from 25 companies in 2025. Trend: 2023 $2,038 · 2024 $2,948 · 2025 $2,189
Food & beverage: $2,177Education: $12
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 12 | $324 |
| Amgen Inc. | 19 | $230 |
| Xeris Pharmaceuticals, Inc. | 15 | $225 |
| Lilly USA, LLC | 7 | $203 |
| Mannkind Corporation | 15 | $193 |
| GlaxoSmithKline, LLC. | 17 | $153 |
| Novo Nordisk Inc | 10 | $138 |
| ABBVIE INC. | 7 | $118 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
Products named: Korlym, AFREZZA, TEPEZZA, TRELEGY ELLIPTA, RECORLEV, KISUNLA, LEQVIO, Rybelsus.
Industry payments across TX — which companies pay providers there.
